Limerik

Piperacillin, the active ingredient in Limerik, is a Penicillin beta‑lactam antibiotic presented as an injectable solution for intravenous use. It treats a range of serious bacterial infections in hospitalized patients. GNH USA supplies Limerik as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Limerik (piperacillin/tazobactam) is used to treat bacterial infections affecting various organ systems.

Complicated intra‑abdominal infections: provides broad‑spectrum coverage including anaerobes. Hospital‑acquired pneumonia: targets resistant Gram‑negative and Gram‑positive pathogens. Community‑acquired pneumonia: covers typical and atypical organisms. Urinary tract infections: effective against complicated UTIs caused by susceptible bacteria. Sepsis and septic shock: used as empiric therapy for severe systemic infections.

Adverse reactions may occur with any intravenous antibiotic.

Common Side Effects: - Diarrhea: mild to moderate gastrointestinal upset. - Nausea: occasional feeling of queasiness. - Rash: transient skin erythema. - Elevated liver enzymes: transient increase in ALT/AST. - Injection site pain: discomfort at the infusion site. - Elevated creatinine: transient rise in renal markers.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Clostridioides difficile‑associated diarrhea: potentially life‑threatening colitis. - Stevens‑Johnson syndrome: severe mucocutaneous reaction. - Hemolytic anemia: destruction of red blood cells. - Seizures: especially in patients with renal impairment. - Severe neutropenia: marked reduction in white blood cells.

Use Limerik with careful clinical monitoring.

Assess renal function: dose adjustment may be required in renal impairment. Review allergy history: avoid in patients with known penicillin or beta‑lactamase inhibitor hypersensitivity. Monitor liver enzymes: watch for hepatic dysfunction during prolonged therapy. Observe for superinfection: secondary infections may develop with prolonged use. Use with caution in the elderly: increased risk of renal and neurologic adverse events. Store at 2‑8°C: keep refrigerated, protect from light, do not freeze or shake.

Drug interactions can affect efficacy or safety.

Major Interactions (Avoid): - Warfarin: potentiates anticoagulant effect, increasing bleeding risk. - Aminoglycosides: may enhance nephrotoxicity when combined. - Methotrexate: can increase serum levels, risking toxicity.

Moderate Interactions (Monitor Closely): - Diuretics: may exacerbate renal impairment, requiring dose review. - Allopurinol: increased risk of rash, monitor skin reactions. - Oral contraceptives: possible reduction in hormonal efficacy, advise alternative contraception.